Member Info for Jet7

GREAT RESEARCH BRAINS!!!!

So Hawky, Two years ago with the share price at 52p, you announce that it is time for the share price to advance. Yet now with a potential blockbuster in phase 3 trials you estimate it at just 30p if it passes. Ok we’ve had the dilution but the company is in a totally different place now. You talk about Rampers but you are saying exactly what suits you.

Brains once again , very good! Embarrassing for Hawkhead!

Certainly not ramping Hawk, that’s just not me. I’ve made my choice and invested and will take what ever comes by that. Your 30p is nearly as bad as Rhodi, I’ve never stated £4.50 but you fail to answer my question regarding Ananda and if you honestly think this will be worth 30p after a successful phase 3 trial , you need to look in the mirror and ask who truly is dilutional!
You have a nice weekend too!

Hawkhead, I think you are talking the product/company down just as I believe Rhodi has been. I have not bothered looking back through all Ananas posts but I do not think that he has ever stated that £4.57 would be the price immediately after results of phase 3 are disclosed. Surely the patent can be extended, you have not taken that into consideration, all products in total , do they have any further products in the pipeline?

I will also disagree with the company itself, I believe they could well be underestimating sales of Med as I believe that guys will buy and try the product even if they don’t require it. It will just take one article in a national paper to launch a product like Med as we have already seen previously this happened around a year or so ago and the consequent media hype went into over drive.

As Daring says everyone has their opinion but I am certainly pleased that I have averaged down and view this share with a degree of excitement as to where it may reach, but your analysis simply does not add up and is in my eyes a bigger joke than Anandas, what if anything apart from the price that you find a joke , has Ananda quoted that is misleading?

If there two areas people will spend money on it is sex and pain relief, if these products both come through with the speed at which they work it is the reason why imo they will be a massive success. No other similar products work in the same way as these will.

Have to disagree with you there, I’d say starts with B and ends in T!

Are you telling me because they have used a product for years that takes 30minutes plus to work they are not going to use Med that works in 5-10 minutes , with the added bonus of having your partner rub it into your loins. Don’t buy it, at the very least it will be used in tandem.

Hawkhead, have to totally agree with Ananda every bloke out there will be wanting to get hold of this gel even if they don’t have a problem with ED the word will get round pretty quickly with this one if it hits the market believe you me!

Rhodi, I am sorry but you seem to be stating different things to suit. Like you I have stated many times previously management have totally screwed long term holders here. But for a person who quotes a top price of 25p now talking about investing £100k is embarrassing, I have believed in the companies products for the last 3 years that I have been invested and have had to invest heavily to bring my average down. You would not even invest in a tank of fuel to go to the AGM now you say you’ll invest at 15p. Well I will say to you that you will certainly be investing because this is going way above that figure this year.

I have no problem with the company bringing in advisors even if it lead to nothing. In the end without the dilution the company had no other option otherwise it would have gone bust, it was the bad management leading up to that period that I have the problem with. That is water under the bridge now and I have stated a share price of between £1-1.50 after phase 3 trials if successful but imo the gut feeling is this could go well north of that figure and you know Ananda figure of £4.50 is possible longer term, one good year of results and good management could lead this company into the big time one way or another , my biggest concern is management but let’s hope they have learnt their lessons.

Unable to buy any shares this morning , it will allow sells though.. Says it all!.

Still ridiculously cheap 13.45p, still a long way north to go from here, just the beginning, GLA!

Sorry Rhodi but I expect better from you! That sounds like an unnecessarily bitter remark, I see this share progressing northwards from here, no need for management to upset the process into the trial results and I believe they have an above average chance of success after previous findings and other similar products already bought to market. Med particularly will be a blockbuster. Perhaps some who invested at the 7p mark will cash in with a profit but investors are becoming aware of the massive potential here and I can see nothing more than the price advancing well above where it stands at present.

Thanks Tommy!

Tommy , Interesting, , that puts a different light on things! Can I ask where you got the info from?

When speaking with a friend of mine this afternoon who is also invested, he casually mentioned that the trial started in September and the first group of results would very likely just have been completed. “That is why the price is shooting up” he said. OMG could he be right ? Each patient is supposed to be on the trial for three months. Maybe people know something!?

May be just may be, although JB and the board have lost us long term holders a bundle of cash , they may now have pulled off a major stroke. The dilution saved the company and I believe the so called negotiators bought in helped in raising these funds. Bottom line is FUM still own 100% rights of MED and other products. Maybe I have it wrong and although the obvious mistakes have been made , keeping these rights may in the medium term be the most brilliant move they have done. Engaging with Lombard who took up a large proportion of stock may lead to wonderful times.

I would be the first to post with an apology if this were the case.

JB and management are the reason this share dived from 70p all the way down to the rights issue price of a lowly 7p. I bought the share at 70p and have continued all the way down to its lows. Long term share holders feel agreived and are well down on their investments, for me this is all about 2019 , no body in their right mind can look beyond that with this management team. I have stated where I am but I pray every day that I am not going to see JB’s mug on Proactive feeding us with any more shite. Keep the chat to 2019 and let’s all be realistic here, can JB be trusted , if he can and I am giving him the benefit of doubt as I have spoken with my money , this can become a blockbuster this year.

Hazrat, your post at 8.45 is wrong in my opinion, where this company stands today it is still massively undervalued at 9p this should be minimum mid teens pence wise and approaching 20p in my view, this is still cheap that is why I have bought in and I shall be buying further. This truly could be a blockbuster in a year or two Which you can now buy for pennies.

Sad to say you are completely correct, I so strongly believe in the products this company have produced but it is SUCH a shame when you feel duped. I all along believed that JB was a genuine person and yet I have had to average down to see a reasonable price. I can somewhat understand how mistakes were made with CSD but the Proactive interviews just stink in hindsight. Long term share holders have been totally stitched up, but fortunately I have seen through the incompetence of management and invested further. Time will tell if I am correct but I think the odds are very much in favour with these products, let’s hope JB can redeem himself , I just think it’s so sad how many of these aim companies are total cons.

Trust me folks, this is just the beginning! I believe this will continue to rise in price throughout the whole year. 2019 is the year of FUM in my eyes, you could have your money invested in a boring FTSE 100 company massively in debt , paying a 4% divi and if you are up or down by the end of the year is anyone’s guess.

With FUM you have a company that has money in the bank is on phase 3 trials of a potential BLOCKBUSTER drug , a pain relief gel which could also be a major player in its own right plus other products. I have said it before , imo this company is massively under valued, I believe this has been plagued by market manipulation of recent times. Make your own choices but this could make you many x your investment. DYOR , good luck all!

Prior to the rights for CSD being returned the share price sat for months between 50p - 70p. Then after the rights to CSD were returned the share price slumped down to the mid 20s - 30p. Then after the proactive interviews and suggested punchy numbers came to nothing , the price declined further still when it was evident that FUM needed a rights issue to fulfil the next stage of MED. CSD is no longer in the equation for FUM it is all about MED a completely different animal. JB is looking for large figures believe you me. Why , whilst in the midst of negotiations regarding Med you would announce punchy numbers to the world is beyond me , if I was a prospective purchaser this would put me off but JB is right this is going to be worth real money if it passes these trials in any form, even with the dilution I still believe JB is looking at £1.00 plus a share. Exciting times, and if he doesn’t get what the board know Med is worth after successful trials this year I would fully support a further rights issue and close out the trials in order to sell the product world wide. This is why one way or another FUM is going to be a multi-bagger if this drug is successful with Phase 3.